Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis

BACKGROUND: Type 2 diabetes mellitus (T2DM) results from insulin resistance and relative insulin deficiency. T2DM treatment is a step-wise approach beginning with lifestyle modifications (for example, diet, exercise), followed by the addition of oral hypoglycemic agents (for example, metformin). Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Antony, Jesmin, Soobiah, Charlene, Hemmelgarn, Brenda, Moher, David, Hutton, Brian, Yu, Catherine H, Majumdar, Sumit R, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702520/
https://www.ncbi.nlm.nih.gov/pubmed/23810103
http://dx.doi.org/10.1186/2046-4053-2-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702520/
https://www.ncbi.nlm.nih.gov/pubmed/23810103
http://dx.doi.org/10.1186/2046-4053-2-47

Ejemplares similares